Effects of rapamycin on angiomyolipomas in patients with tuberous sclerosis;Efectos de la rapamicina en los angiomiolipomas de pacientes con esclerosis tuberosa

Nefrologia

Volumn 31, Issue 3, 2011, Pages 292-298

  López, C Cabrera ^a   Marti T ^a   Catala V ^a   Torres, F ^a   Mateu, S ^a   Castán, J Ballarín ^a   Balcells, R Torra ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Angiomyolipoms; Rapamycin; Tuberous sclerosis

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; RAPAMYCIN;

ADOLESCENT; ADULT; ANGIOMYOLIPOMA; ARTICLE; CHILD; CLINICAL TRIAL; FEMALE; HUMAN; MALE; PHASE 4 CLINICAL TRIAL; TUBEROUS SCLEROSIS;

ADOLESCENT; ANGIOMYOLIPOMA; ANTIBIOTICS, ANTINEOPLASTIC; CHILD; FEMALE; HUMANS; MALE; SIROLIMUS; TUBEROUS SCLEROSIS; YOUNG ADULT;

EID: 79958284085     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: 10.3265/Nefrologia.pre2011.Apr.10812     Document Type: Article

References (21)

1. Crino PB, Nathason KL, Petri Henske E. The tuberous sclerosis complex. N Engl J Med 2006;355:1345-56.
2. Dabora SL, Jozwiak S, Franz DN, Roberts PS, Nieto A, Chung J, et al. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet 2001;68:64-80.
3. Yamakado K, Tanaka N, Nakagawa T, Kobayashi S, Yanagawa M, Takeda K. Renal angiomyolipoma: relationships between tumor size, aneurysm formation, and rupture. Radiology 2002;225:78-82.
4. Ewalt DH, Diamond N, Rees C, Sparagana SP, Delgado M, Batchelor L, et al. Long-term outcome of transcatheter embolization of renal angiomiolipomas due to tuberous sclerosis complex. J Urol 2005; 174:1764-6.
5. Van Slegtenhorst M, De Hoogt R, Hermans C, Nellist M, Janssen B, Verhoef S, et al. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 1997;277(5327):805-8.
6. Consortium ECTS, 1993. Identification and characterization of the tuberous sclerosis gene on chromosome 16. The European Chromosome 16 Tuberous Sclerosis Consortium. Cell 1993;75(7):1305-15.
7. Goncharova EA, Goncharov DA, Eszterhas A, Hunter DS, Glassberg MK, Yeung RS, et al. Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation. A role for the TSC2 tumor suppressor gene in pulmonary lymphangioleiomyomatosis (LAM). J Biol Chem 2002;277(34):30958-67.
8. Dixon WJ, Massey FJ. Introduction to statistical analysis (4th ed.). New York: McGraw-Hill, 1983;281-4.
9. Chernick MR, Liu CY. The saw-toothed behavior of power versus sample size and software solutions: single binomial proportion using exact methods. The American Statistician 2002;56:149-55.
10. Ito N, Rubin GM. Gigas, a Drosophila homolog of tuberous sclerosis gene product-2, regulates the cell cycle. Cell 1999;96(4):529-39.
11. Potter CJ, Huang H, Xu T. Drosophila Tsc1 functions with Tsc2 to antagonize insulin signaling in regulating cell growth, cell proliferation, and organ size. Cell 2001;105(3):357-68.
12. Tapon N, Ito N, Dickson BJ, Treisman JE, Hariharan IK. The Drosophila tuberous sclerosis complex gene homologs restrict cell growth and cell proliferation. Cell 2001;105(3):345-55.
13. Stocker H, Radimerski T, Schindelholz B, Wittwer F, Belawat P, Daram P, et al. Rheb is an essential regulator of S6K in controlling cell growth in Drosophila. Nat Cell Biol 2003;5(6):559-65.
14. Zhang Y, Gao X, Saucedo LJ, Ru B, Edgar BA, Pan D. Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins. Nat Cell Biol 2003;5(6):578-81.
15. Kenerson HL, Aicher LD, True LD, Yeung RS. Activated mammalian target of sirolimus pathway in the pathogenesis of tuberous sclerosis complex renal tumors. Cancer Res 2002;62(20):5645-50.
16. Wienecke R, Fackler I, Linsemaier U, Mayer K, Licht T, Kretzler M. Antitumoral activity of rapamycin in renal angiomyolipomas associated with tuberous sclerosis complex. Am J Kidney Dis 2006;48:E27-29.
17. Franz DN, Leonard J, Tudor C, Chuck G, Care M, Sethuraman G, et al. Rapamycin causes regression of astrocytomas in tuberosus sclerosis complex. Ann Neurol 2006;59:490-8.
18. Leonard J, Tudor C et al. Rapamycin causes regression of astrocytomas in tuberosus sclerosis complex. Ann Neurol 2006;59:490-8.
19. Herry I, Neukirsh C, Debray MP et al. Dramatic effect of sirolimus on renal angiomyolipomas in a patient with tuberosu sclerosis complex. Eur J Internal Med 2007; 18: 76-77.
20. Bissler JJ, McCormack FX, Young LR, Elwing JM, Chuck G, Leonard JM, et al. Sirolimus for angiomyolipoma in tuberousclerosis complex or lymphangioleiomyomatosis. N Engl J Med 2008;358:140-51.
21. Bissler JJ, McCormack FX, Young LR. Efficacy and safety of sirolimus for angiomyolipoma in patients with tuberous sclerosis complex and linfagioleiomyomatosis. San Diego: ASN, Nov 2006.